Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005200104> ?p ?o ?g. }
- W3005200104 endingPage "730" @default.
- W3005200104 startingPage "717" @default.
- W3005200104 abstract "Anti-PD1 treatment has improved the survival of metastatic melanoma patients, yet it is unknown which patients benefit from the treatment. In this exploratory study, we aimed to understand the effects of anti-PD1 therapy on the patients' immune system and discover the characteristics that would result in successful treatment. We collected peripheral blood (PB) samples from 17 immuno-oncology-naïve metastatic melanoma patients before and after 1 and 3 months of anti-PD1 therapy. In addition, matching tumor biopsies at the time of diagnosis were collected for tissue microarray. The complete blood counts, PB immunophenotype, serum cytokine profiles, and tumor-infiltrating lymphocytes were analyzed and correlated with the clinical data. Patients were categorized based on their disease control into responders (complete response, partial response, stable disease > 6 months, N = 11) and non-responders (progressive disease, stable disease ≤ 6 months, N = 6). During therapy, the PB natural killer T (NKT) cell frequency, expression of CD25 and CD45RO on cytotoxic natural killer (NK) cells, and serum CXC chemokine levels were significantly increased in responders. Furthermore, higher age together with age-associated characteristics from PB, lower frequency of PB-naïve CD8+ T cells, and elevated levels of serum MCP-4 and OPG were discovered as baseline predictors of treatment response. We therefore propose that in addition to T cells, anti-PD1 treatment is associated with NK- and NKT-cell population dynamics, and that the age-associated characteristics from PB together with older age may contribute to prolonged PFS in anti-PD1-treated melanoma patients." @default.
- W3005200104 created "2020-02-14" @default.
- W3005200104 creator A5004992206 @default.
- W3005200104 creator A5006566356 @default.
- W3005200104 creator A5008868111 @default.
- W3005200104 creator A5009095590 @default.
- W3005200104 creator A5019145336 @default.
- W3005200104 creator A5023554856 @default.
- W3005200104 creator A5030901471 @default.
- W3005200104 creator A5044690676 @default.
- W3005200104 creator A5071945736 @default.
- W3005200104 date "2020-02-08" @default.
- W3005200104 modified "2023-10-14" @default.
- W3005200104 title "Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients" @default.
- W3005200104 cites W1192355649 @default.
- W3005200104 cites W1524533358 @default.
- W3005200104 cites W1549733910 @default.
- W3005200104 cites W1609608388 @default.
- W3005200104 cites W1978586979 @default.
- W3005200104 cites W1985213644 @default.
- W3005200104 cites W1994596411 @default.
- W3005200104 cites W1999083645 @default.
- W3005200104 cites W2019607817 @default.
- W3005200104 cites W2024852458 @default.
- W3005200104 cites W2035121127 @default.
- W3005200104 cites W2048657818 @default.
- W3005200104 cites W2052255673 @default.
- W3005200104 cites W2066671159 @default.
- W3005200104 cites W2112121482 @default.
- W3005200104 cites W2128035403 @default.
- W3005200104 cites W2132976465 @default.
- W3005200104 cites W2146313292 @default.
- W3005200104 cites W2338374686 @default.
- W3005200104 cites W2397739282 @default.
- W3005200104 cites W2403987468 @default.
- W3005200104 cites W2462014591 @default.
- W3005200104 cites W2519649019 @default.
- W3005200104 cites W2560367415 @default.
- W3005200104 cites W2572174216 @default.
- W3005200104 cites W2577986390 @default.
- W3005200104 cites W2588635414 @default.
- W3005200104 cites W2589298520 @default.
- W3005200104 cites W2597872842 @default.
- W3005200104 cites W2606269330 @default.
- W3005200104 cites W2726861941 @default.
- W3005200104 cites W2744632602 @default.
- W3005200104 cites W2746148521 @default.
- W3005200104 cites W2775057452 @default.
- W3005200104 cites W2790067792 @default.
- W3005200104 cites W2793229570 @default.
- W3005200104 cites W2808441345 @default.
- W3005200104 cites W2809124723 @default.
- W3005200104 cites W2890056446 @default.
- W3005200104 cites W2890499629 @default.
- W3005200104 cites W2910489061 @default.
- W3005200104 cites W2913289941 @default.
- W3005200104 cites W2918297277 @default.
- W3005200104 cites W2921443070 @default.
- W3005200104 cites W2945224722 @default.
- W3005200104 cites W2949836841 @default.
- W3005200104 cites W2969246868 @default.
- W3005200104 cites W580485635 @default.
- W3005200104 doi "https://doi.org/10.1007/s00262-020-02497-9" @default.
- W3005200104 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7183505" @default.
- W3005200104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32036449" @default.
- W3005200104 hasPublicationYear "2020" @default.
- W3005200104 type Work @default.
- W3005200104 sameAs 3005200104 @default.
- W3005200104 citedByCount "9" @default.
- W3005200104 countsByYear W30052001042020 @default.
- W3005200104 countsByYear W30052001042021 @default.
- W3005200104 countsByYear W30052001042022 @default.
- W3005200104 countsByYear W30052001042023 @default.
- W3005200104 crossrefType "journal-article" @default.
- W3005200104 hasAuthorship W3005200104A5004992206 @default.
- W3005200104 hasAuthorship W3005200104A5006566356 @default.
- W3005200104 hasAuthorship W3005200104A5008868111 @default.
- W3005200104 hasAuthorship W3005200104A5009095590 @default.
- W3005200104 hasAuthorship W3005200104A5019145336 @default.
- W3005200104 hasAuthorship W3005200104A5023554856 @default.
- W3005200104 hasAuthorship W3005200104A5030901471 @default.
- W3005200104 hasAuthorship W3005200104A5044690676 @default.
- W3005200104 hasAuthorship W3005200104A5071945736 @default.
- W3005200104 hasBestOaLocation W30052001041 @default.
- W3005200104 hasConcept C126322002 @default.
- W3005200104 hasConcept C139563560 @default.
- W3005200104 hasConcept C143998085 @default.
- W3005200104 hasConcept C147483822 @default.
- W3005200104 hasConcept C167672396 @default.
- W3005200104 hasConcept C196166836 @default.
- W3005200104 hasConcept C203014093 @default.
- W3005200104 hasConcept C2777658100 @default.
- W3005200104 hasConcept C2908647359 @default.
- W3005200104 hasConcept C502942594 @default.
- W3005200104 hasConcept C71924100 @default.
- W3005200104 hasConcept C8891405 @default.
- W3005200104 hasConcept C99454951 @default.
- W3005200104 hasConceptScore W3005200104C126322002 @default.